Craig Horbinski
North Western University
H-index: 72
Asia-Bangladesh
Top articles of Craig Horbinski
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
2024/1/1
Predictors of salvage therapy for parasagittal meningiomas treated with primary surgery, radiosurgery, or surgery plus adjuvant radiotherapy
Journal of Clinical Neuroscience
2024/6/1
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care
2024/4/30
494 Evaluating ERK1 2 Phosphorylation as a Predictive Biomarker for Survival in Recurrent Glioblastoma Patients: A REMARK Criteria-guided Analysis of a Clinical Trial Cohort …
Neurosurgery
2024/4/1
Characterization of Immune Cell Heterogeneity, Key B Cell Subtypes, and Macrophages Functions Using Multiplex Immunofluorescence and Single-cell RNA Sequencing in Chordomas
Neurosurgery
2024/4/1
Blood-Brain Barrier Opening with Ultrasound Augments Doxorubicin and Anti-PD-1 Therapy Efficacy, Intracranial Immune Activation, and Prolongs Survival in Preclinical Glioma Models
Neurosurgery
2024/4/1
1228 Comprehensive T-cell Profiling in Chordomas: Single-cell RNA-Seq and TCR Profiling Analysis Uncover Antitumor and Exhaustion Phenotypes for Targeted Immunotherapies
Neurosurgery
2024/4/1
Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression
Nature communications
2024/3/5
Fatima Khan
H-Index: 4
Katie Frenis
H-Index: 7
Jason Miska
H-Index: 15
Craig Horbinski
H-Index: 43
Peiwen Chen
H-Index: 20
Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas
Journal of Clinical Investigation
2024/2/15
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Clinical Cancer Research
2024/1/17
Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice
The Journal of clinical investigation
2024/1/16
Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease
Annals of case reports
2024
Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
2023/1/1
The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma
JCI insight
2023/7/7
A novel BRAF:: PTPRN2 fusion in meningioma: a case report
Acta Neuropathologica Communications
2023/12/8
Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
The Journal of clinical investigation
2023/6/15
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Nature medicine
2023/12
Glioma Response to IDH Inhibition: Real-World Experience
Clinical Cancer Research
2023/12/1
Craig Horbinski
H-Index: 43
Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence
Clinical Cancer Research
2023/12/1
NCCN CNS tumor guidelines update for 2023
2023/12/1
Craig Horbinski
H-Index: 43